The U.S. Food and Drug Administration on Friday put its stamp of approval on Pfizer’s COVID-19 vaccine for children, paving the way for 28 million juvenile vaccinations.

The approval, which calls for a lower dose of the vaccine for kids between the ages of 5 and 11, is the second-to-last step in the approval process; next, officials with the Centers for Disease Control and Prevention will analyze the vaccine to determine whether they agree with the FDA. An official ruling is expected to come sometime next week.

“As a mother and a physician, I know that parents, caregivers, school staff, and children have been waiting for today’s authorization,” says acting FDA Commissioner Dr. Janet Woodcock. “Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy.” The vaccine is expected to be distributed as soon as it receives final approval, Woodcock adds.

Do you plan on getting your kids vaccinated? Why or why not?

More about:

Pro Sports